Chinese Clinical Oncology

Aims & Scope

The Chinese Clinical Oncology (Print ISSN 2304-3865; Online ISSN 2304-3873; Chin Clin Oncol; CCO) publishes articles that describe new findings in the field of oncology, and provides current and practical information on diagnosis, prevention and clinical investigations of cancer.

Specific areas of interest include, but are not limited to: multimodality therapy, biomarkers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to cancer.

The aim of the Journal is to provide a forum for the dissemination of original research articles as well as review articles in all areas related to cancer.

It is an international, peer-reviewed journal with a focus on cutting-edge findings in this rapidly changing field.

To that end, Chin Clin Oncol is dedicated to translating the latest research developments into best multimodality practice.

The journal features a distinguished editorial board, which brings together a team of highly experienced specialists in cancer treatment and research.

The diverse experience of the board members allows our editorial panel to lend their expertise to a broad spectrum of cancer subjects.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.5
2024	2.10

Journal Rank

Year	Value
2024	9137

Journal Citation Indicator

Year	Value
2024	311

SJR (SCImago Journal Rank)

Year	Value
2024	0.632

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	40

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Epidemiology of ovarian cancer

  Citation: 197

  Authors: Patricia, Lourdes Adriana, Kassandra

• Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates

  Citation: 181

  Authors: Andrew J., Yun Shin

• Advanced magnetic resonance imaging in glioblastoma: a review

  Citation: 156

  Authors: Gaurav, Gregory S., Spyridon, Rahul, Kiran, Joshua D., Wenyin

• Epidemiology of gallbladder cancer in India

  Citation: 154

  Authors: Usha, Nikhil, Dimple, Priyanka, Vinay K.

• Gallbladder cancer: epidemiology and genetic risk associations

  Citation: 143

  Authors: Mikayla A., Lorena, Lewis R.

• Biliary carcinomas: pathology and the role of DNA mismatch repair deficiency

  Citation: 136

  Authors: Vitor Werneck Krauss, Gokce, Tanisha D., Maeve, David S., Ghassan K., Jinru

• The emerging role of oncolytic virus therapy against cancer

  Citation: 107

  Authors: Luke, Kah-Whye

• Biliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations

  Citation: 104

  Authors: Lorena, Essa A., Taofic, Lewis R.

• Genetic and epigenetic landscape of nasopharyngeal carcinoma

  Citation: 94

  Authors: Wei, Hong, Arthur Kwok Leung, Maria Li

• Neoadjuvant treatment for HER2-positive breast cancer

  Citation: 80

  Authors: Masahiro, Masakazu

---